Status:
COMPLETED
Women-Focused HIV Prevention in the Western Cape
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsors:
Medical Research Council, South Africa
Conditions:
HIV
Substance Abuse
Eligibility:
FEMALE
18-33 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to test the effectiveness of a woman-focused HIV prevention intervention combined with voluntary counseling and testing (VCT), compared to VCT only, and VCT combined with ...
Detailed Description
Surveillance data indicate that HIV risk and substance use is a serious problem among South African women. This study, funded by the National Institute on Child Health and Human Development (NICHD), b...
Eligibility Criteria
Inclusion
- To be eligible for the study, participants must be: (a) female; (b) report use of at least two drugs-alcohol, marijuana, methamphetamine (tik), Mandrax (methaqualone), cocaine (crack and/or powder), heroin (Thai White), glue, MDMA (ecstasy), or LSD-at least once a week in the past 90 days; (c) be sexually active within the past 30 days with a male partner; (d) be aged 18 to 33 years; (e) live in the communities around the airport; and (f) provide verbal consent to be screened for eligibility and written consent to participate in the study.
Exclusion
- If participants do not meet all of the inclusion criteria, they will be excluded from the study.
Key Trial Info
Start Date :
September 26 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT00729391
Start Date
September 26 2008
End Date
March 1 2012
Last Update
May 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cape Town, Western Cape, South Africa